Vaccination of chimpanzees with a multicomponent DNA-protein prime-boost regimen provides an enhanced recovery following heterologous HCV challenge. by Heeney, J, Drexhage, J, Verstrepen, B, Rollier, C, Mares, G, Jacobs, D, Depla, E, Maertens, G, Brinster, C, Fournillier, A, Verschoor, E, Inchauspe, G

Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting. by Rollier, C, Verschoor, E, Paranhos-Baccala, G, Drexhage, J, Verstrepen, B, Berland, J, Himoudi, N, Barnfield, C, Liljestrom, P, Lasarte, J, Ruiz, J, Inchauspe, G, Heeney, J

T and B cell responses to multivalent prime-boost DNA and viral vectors vaccine combinations against Hepatitis C virus in non-human primates by Rollier, C, Verschoor, E, Verstrepen, B, Drexhage, J, Paranhos-Baccala, G, Liljeström, P, Sutter, G, Arribillaga, L, Lasarte, J, Bartosch, B, Cosset, F, Inchauspe, G, Heeney, J

Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response. by Rollier, C, Depla, E, Drexhage, J, Verschoor, E, Verstrepen, B, Fatmi, A, Brinster, C, Fournillier, A, Whelan, J, Whelan, M, Jacobs, D, Maertens, G, Inchauspé, G, Heeney, J